DTP-23-019 PRB next, production of 40MG capsules of z-endoxifen
Ended Awarded Last action
- Contract number
- 75N91023F00002
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Recro Pharma, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $140,000
Award facts
- Contract value 100% obligated
- $140,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $140,000 |
About this award
The federal contract award with ID 75N98019D00058|75N91023F00002 was issued by the National Cancer Institute, a civilian agency under the U.S. Department of Health and Human Services. The $140,000.00 firm fixed-price delivery order was awarded to Societal Cdmo San Diego, LLC, doing business as Irisys Inc., a self-certified small disadvantaged business. The contract is for the production of 40mg capsules of Z-Endoxifen under the Drug Formulation and Manufacturing Contracts 2019 IDIQ vehicle. The award has no set-aside designation and the work will be performed in San Diego, California. Societal Cdmo San Diego, LLC is a subsidiary of Recro Pharma, Inc., a for-profit manufacturer that has a history of providing pharmaceutical products and services to federal agencies, including the Department of Veterans Affairs.
Quick answers
Who was awarded contract 75N91023F00002?
75N91023F00002 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on April 24, 2023.
How much is contract 75N91023F00002 worth?
The government has obligated $140,000 on 75N91023F00002.
Is contract 75N91023F00002 an order under another contract?
Yes. 75N91023F00002 is a delivery order under 75N98019D00058, an indefinite delivery contract, on Drug Formulation and Manufacturing Contracts 2019.
Was contract 75N91023F00002 competed?
The extent of competition for 75N91023F00002 was full and open competition after exclusion of sources. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award